Showing results (381-390 of 473) with videos related to
Sort By:
Pageof 48
The American Surgeon|April 26, 2022
Intraoperative Ultrasound Guided Laparoscopic Spleen-Preserving Distal Pancreatectomy for Primitive Neuroendocrine Tumors in a Pediatric Patient With MEN-1Katlyn G McKay, David N Hanna, Laura Martin, et al.Scientific Reports|June 20, 2015
The transcription factor NR4A1 is essential for the development of a novel macrophage subset in the thymusRobert Tacke, Ingo Hilgendorf, Hannah Garner, et al.The Medical Journal of Australia|September 2, 1996
An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995J N Hanna, S A Ritchie, D A Phillips, et al.Journal of Surgical Education|June 13, 2022
Pulling Back from the Brink: A Multi-Pronged Approach to Address General Surgery Resident Clinical Work Hour AdherenceRachael Acker, Robert A Swendiman, Valerie L Luks, et al.ACS Chemical Biology|March 11, 2020
Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the LungsQing Li, Chingshen Chan, Norman Peterson, et al.Cancer Immunology Research|August 2, 2022
Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and ActivityAndrew D Tieniber, Andrew N Hanna, Benjamin D Medina, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancerZ T Hammoud, K A Kesler, M K Ferguson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancerG J Weiss, R Rosell, F Fossella, et al.Cell|April 16, 2013
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposalLeo M Carlin, Efstathios G Stamatiades, Cedric Auffray, et al.Biochemical Pharmacology|October 15, 1987
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acidD E Griswold, P J Marshall, E F Webb, et al.Pageof 48